Genedata Biopharma Platform Adopted by Genmab to Streamline Biotherapeutics R&D Operations

Genedata E2E software solution to increase speed and efficiency of discovery and development of Genmab’s next-generation cancer therapies Basel, Switzerland ‒ Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced that Genmab, an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer, [...]

Arcis Biotechnology and Opentrons sign distribution agreement

Providing researchers with an automated solution for two-step nucleic acid sample preparation   Daresbury, UK, 09 July 2019: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has signed a commercial distribution agreement with Opentrons, the developer of affordable pipetting robots. The agreement allows Opentrons to directly distribute Arcis’ sample preparation kits to [...]

Olympus Europe and Cytosurge partner to enhance pharma drug development and single cell research

Zurich / Glattbrugg & Hamburg | Olympus Europe and Cytosurge have partnered in order to accelerate common innovation of next-generation tools for single cell experiments and to expand the distribution of the versatile FluidFM BOT single cell research tool. The ultimate goal of the new co-marketing partnership is to fight diseases and improve human health [...]

Extensive CAR-T Cell Range for Research & Immunotherapy

AMSBIO announce new, best-in-class CAR-T cells, engineered CAR-T target cells, PBMC, cell media and activation beads in response to the rapid growth in research on the therapeutic uses of CAR-T cells. All CAR-T cell products from AMSBIO are T cells produced from either a group of donors or from individual donor transduced with CAR (Chimeric antigen receptor) [...]

DRVISION wins NIMH SBIR grant to develop the Intelligent Connectomics Analysis platform within Aivia

DRVISION wins up to 3.27 million USD NIMH SBIR grant to develop the Intelligent Connectomics Analysis platform within Aivia BELLEVUE, WA, UNITED STATES -- DRVISION Technologies, a pioneer in computer vision and the world’s leading AI microscopy software company has been awarded up to 3.27 million USD from the National Institute of Mental Health (NIMH) to [...]

CRISPR Researchers to Benefit from COBO Technologies and SCIEX Partnership

A co-marketing agreement between the two companies will offer PIPPR®, a unique protein expression analysis platform, developed for CRISPR applications and powered by SWATH® Acquisition. PIPPR is uniquely and specifically designed to help CRISPR researchers. COPENHAGEN, Denmark--COBO Technologies, a company specialised in quality control services and products in genome editing, today announces a new partnership [...]

The Fitting Solution

  Some laboratories have minimal spaces that make the installation of a full-sized Biological Safety Cabinet burdensome. Small doors and narrow walkways are also a common problem when transporting regular-sized cabinets. With this, Esco provides you with a compact-sized solution! Introducing AC2-2E_, the energy-efficient, quiet, Biosafety Cabinet that can fit into small spaces! The EN [...]

Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC

Acquisition strengthens Bruker's portfolio of high-performance PET molecular imaging solutions ZURICH, Switzerland -- Bruker today announced that it has acquired PMOD Technologies LLC, a highly respected provider of research-use-only software for preclinical and molecular imaging, with a focus on molecular quantification and pharmacokinetic modeling. The PMOD software is widely used for the analysis of positron [...]

Horizon Discovery’s SMARTvector shRNA technology deployed in Celyad’s successful IND filing for next-generation CAR-T cell therapy, CYAD-02

Phase 1 trial scheduled for early 2020 will be first CAR-T cell therapy clinical trial to employ SMARTvector technology Horizon will receive a milestone payment for the successful IND filing of CYAD-02, autologous NKG2D-based CAR-T candidate Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”), a company driving the application of gene editing and gene modulation [...]

James Green Named President and CEO of Harvard Bioscience

HOLLISTON, Mass. -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that James Green has been named President and Chief Executive Officer of the Company by its Board of Directors, effective immediately. Additionally, Harvard Bioscience’s Board has appointed Bertrand Loy as Lead Independent Director. Green has been a member of the Company’s Board since April 2015, and Chairman of the Board since June 2017, and [...]

Access IBO on Knowledge Center